COVID-19 Virtual Care at Home

This multicentre prospective cohort trial is designed to demonstrate effectiveness and efficiency of a virtual care model for the management of COVID-19 patients isolating at home. The investigators have reoriented existing technology and networks for this research project. The investigators are amplifying our existing virtual care platform VIRTUES, combining it with home monitoring of COVID-19 patients, to provide real-time evidence, harmonize data collection, and share data provincially to mitigate the impact of the rapid spread of the virus. The study will facilitate early detection of complications associated with the disease, treatment and management of COVID-19 patients at home. The research will be conducted provincially in Ontario. This initiative will provide evidence to inform clinical and health system management and public health response to COVID-19 patients isolating at home.

COVID-19, SARS-CoV-2, VIRTUES, Virtual Care Management, Virtual Care, Patient Satisfaction, Anxiety, Emergency Visits, Oxygen Saturation, Quality of Life

VIRTUES COVID-19 Care at Home Platform The components of the platform will include: Vital sign monitoring, including O2 saturation with a home-based pulse oximeter, temperature and respiratory rate performed three times per day (a notification to do this will be sent from the app), with the option of doing assessments more frequently if needed. Study patients will be provided monitoring devices to collect this data. Symptom logs will be entered by the patients. Feedback to the patient by the local COVID-19 care team for any action: Two-way communication between the patient and the COVID-19 care team Ability for team members to see all prior notes in order to have continuity of care Reports of these interactions are transmitted to the patient's health record Current information on COVID-19 as per the Public Health Agency of Canada

The primary outcome measure is patient satisfaction as measured from a patient satisfaction questionnaire at 14 days.

The secondary outcome measures will include the number of patients that require an Emergency Department visits during the observation period of 14 days.

The secondary outcome measures will include the health status measures of the EuroQuality of Life Five Dimensions (EQ-5D-5L) at 14 days. Scoring is Level 1 to 5 for each dimension; higher scores meaning worse health status.

Inclusion Criteria: All COVID-19 positive patients of age 18 or above Participant must communicate in English or French language An email address and account Exclusion Criteria: Unable or unwilling to provide informed consent